BioSpace News Archive

Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, and Executive Vice President, Joakim Weidemanis, will be presenting at the Barclays Industrial Select Conference in Miami, Florida on Wednesday, February 20, 2019 at 9:45 a.m. ET.

Arcus Biosciences, Inc. announced that Terry Rosen, Ph.D., Chief Executive Officer, will participate in a fireside chat at the 8th Annual Leerink Partners Global Healthcare Conference on Wednesday, February 27, 2019 at 11:30 am ET at the Lotte New York Palace, in New York, NY.

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Barclays Global Healthcare Conference in Miami, Fla. on March 12, 2019.

Puma Biotechnology, Inc., a biopharmaceutical company, will host a conference call at 1:30 p.m. PST/4:30 p.m. EST on Thursday, February 28, 2019 following release of its fourth quarter and full year 2018 financial results.

Real-Time Prescription Benefit tool, now available for Cigna health care providers and customers, makes it easier to identify opportunities to decrease out of pocket costs.

DaVita Inc. announced results for the quarter and year ended December 31, 2018.

The University of Minnesota Medical School continues its legacy of advancing cell replacement therapies with a scientific breakthrough that highlights the promise of cell therapies for muscular dystrophy.

Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announced the availability of preliminary results from the Phase II CALYPSO study of the savolitinib / Imfinzi® (durvalumab) combination in a cohort of patients with metastatic papillary renal cell carcinoma (“PRCC”), an investigator initiated study led by Professor Thomas Powles, Lead for Solid Tumour Research at Barts Cancer Institute, and sponsored by Queen Mary University of London.

Neptune Wellness Solutions Inc. (“Neptune” or the “Corporation”) (NASDAQ: NEPT) (TSX: NEPT), today announced its financial and operating results for the 3-month period ended December 31, 2018

Feinstein Institute for Medical Research Assistant Professor and Junior Faculty Researcher Safiya Richardson, MD, has been awarded a five-year, $850,000 National Institutes of Health (NIH) grant to support her work in creating tools that help doctors make evidence-based clinical decisions.